ATE378596T1 - Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen - Google Patents

Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen

Info

Publication number
ATE378596T1
ATE378596T1 AT01975445T AT01975445T ATE378596T1 AT E378596 T1 ATE378596 T1 AT E378596T1 AT 01975445 T AT01975445 T AT 01975445T AT 01975445 T AT01975445 T AT 01975445T AT E378596 T1 ATE378596 T1 AT E378596T1
Authority
AT
Austria
Prior art keywords
proteolytic activities
substrates
assays
throughput assay
proteins
Prior art date
Application number
AT01975445T
Other languages
English (en)
Inventor
James Schmidt
Robert Stafford
Original Assignee
U S Medical Res Inst Of Infect
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U S Medical Res Inst Of Infect filed Critical U S Medical Res Inst Of Infect
Application granted granted Critical
Publication of ATE378596T1 publication Critical patent/ATE378596T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/842—Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01975445T 2000-09-25 2001-09-25 Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen ATE378596T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23505000P 2000-09-25 2000-09-25

Publications (1)

Publication Number Publication Date
ATE378596T1 true ATE378596T1 (de) 2007-11-15

Family

ID=22883879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01975445T ATE378596T1 (de) 2000-09-25 2001-09-25 Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen

Country Status (7)

Country Link
US (3) US6762280B2 (de)
EP (1) EP1419390B1 (de)
AT (1) ATE378596T1 (de)
AU (1) AU2001294771A1 (de)
CA (1) CA2451909C (de)
DE (1) DE60131468D1 (de)
WO (1) WO2002025284A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563874B2 (en) * 1998-08-31 2009-07-21 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
DE60131468D1 (de) * 2000-09-25 2007-12-27 U S Medical Res Inst Of Infect Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen
ATE380342T1 (de) * 2001-05-07 2007-12-15 Hipep Lab Peptidimmobilisierte grundplatte und vefahren zum testen eines zielproteins unter verwendung derselben
US7332567B2 (en) 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7208285B2 (en) 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US7374896B2 (en) 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7183066B2 (en) 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
WO2004031355A2 (en) * 2002-10-01 2004-04-15 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
EP1580196B1 (de) * 2002-12-12 2010-08-04 Japan Science And Technology Agency Überwachungsprotein zur messung der proteinverarbeitung
WO2004102215A1 (en) * 2003-05-07 2004-11-25 The United States Of America, As Represented By The Secretary Of The Navy Naval Research Laboratory Assay for testing neurotoxin vaccine efficacy
US20050079566A1 (en) * 2003-09-10 2005-04-14 Caterer Nigel Robert Analytical methods for determination of proteolytic cleavage at specific sites
US7611856B2 (en) * 2003-11-05 2009-11-03 Los Alamos National Security, Llc Mass spectrometry-based methods for detection and differentiation of botulinum neurotoxins
WO2005076785A2 (en) * 2003-12-19 2005-08-25 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
EP2153848A3 (de) * 2005-01-27 2010-07-21 The Regents of the University of California Monoklonale therapeutische Antikörper zur Neutralisierung von Botulin-Neurotoxinen
CA2605160A1 (en) 2005-04-05 2006-10-05 Allergan, Inc. Clostridial toxin activity assays
EP2293064B1 (de) * 2005-04-05 2012-04-04 Allergan, Inc. Lipophile, farbstoffbasierte FRET-Assays für die Clostridientoxinaktivität
ATE518882T1 (de) 2005-09-19 2011-08-15 Allergan Inc Mit clostridientoxin aktivierbare clostridientoxine
DE102006019447A1 (de) * 2006-04-24 2007-10-25 Dressler, Dirk, Dr. Markierung von Botulinum Toxin
EP2044211A2 (de) * 2006-06-09 2009-04-08 Bio Pur AG Verfahren zum nachweis enzymatischer reaktionen
WO2009008916A2 (en) 2007-03-22 2009-01-15 The Regents Of The University Of Californina Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US8753831B2 (en) 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
US8067192B2 (en) * 2007-06-05 2011-11-29 City Of Hope Methods for detection of botulinum neurotoxin
US8962677B2 (en) * 2007-07-12 2015-02-24 Acumen Pharmaceuticals, Inc. Methods of restoring cognitive ability using non-peptidic compounds
US9006283B2 (en) 2007-07-12 2015-04-14 Acumen Pharmaceuticals, Inc. Methods of modifying amyloid β oligomers using non-peptidic compounds
US20110098309A1 (en) * 2007-07-12 2011-04-28 Acumen Pharmaceuticals, Inc. Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds
US9217024B2 (en) 2007-12-18 2015-12-22 Acumen Pharmaceuticals, Inc. ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
US9000131B2 (en) * 2008-07-31 2015-04-07 The Regents Of The University Of California Antibodies that neutralize botulinum neurotoxins
WO2011047241A1 (en) * 2009-10-18 2011-04-21 Department Of The Us Army Enhanced substrates for the protease activity of serotype a botulinum neurotoxin
US9243057B2 (en) 2010-08-31 2016-01-26 The Regents Of The University Of California Antibodies for botulinum neurotoxins
RU2549463C1 (ru) * 2013-12-03 2015-04-27 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ определения ботулинического нейротоксина типа а на основе иммунодетекции, сопряженной с полимеразной цепной реакцией
US11293927B2 (en) 2018-04-30 2022-04-05 Ribon Therapeutics, Inc. Screening methods for PARP modulators
IL272002A (en) 2020-01-13 2021-07-29 The Israel Institute Of Biological Res Iibr Methods for identifying anti clostridial neurotoxin compounds
CN114539362B (zh) * 2022-04-25 2022-07-26 中国疾病预防控制中心传染病预防控制所 一种肉毒毒素特异性底物肽、检测试剂盒和检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
US5605809A (en) * 1994-10-28 1997-02-25 Oncoimmunin, Inc. Compositions for the detection of proteases in biological samples and methods of use thereof
US5965699A (en) * 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
FR2809733B1 (fr) 2000-06-02 2004-04-30 Inst Nat Sante Rech Med Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
DE60131468D1 (de) * 2000-09-25 2007-12-27 U S Medical Res Inst Of Infect Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen

Also Published As

Publication number Publication date
US20030077685A1 (en) 2003-04-24
CA2451909C (en) 2010-12-21
US6762280B2 (en) 2004-07-13
EP1419390B1 (de) 2007-11-14
AU2001294771A1 (en) 2002-04-02
US7157553B2 (en) 2007-01-02
CA2451909A1 (en) 2002-03-28
WO2002025284A2 (en) 2002-03-28
DE60131468D1 (de) 2007-12-27
US7034107B2 (en) 2006-04-25
EP1419390A2 (de) 2004-05-19
US20040146963A1 (en) 2004-07-29
WO2002025284A3 (en) 2003-09-18
US20050287622A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
ATE378596T1 (de) Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen
Beynon et al. Proteolytic enzymes: a practical approach
KR940019867A (ko) 내독소 검정용 반응제 및 이를 사용하는 내독소 검정방법
Freije et al. Chemically modified, immobilized trypsin reactor with improved digestion efficiency
WO2003022028A3 (en) Methods, reagents, kits and apparatus for protein function analysis
ATE393228T1 (de) Fusionsproteine und deren verwendung zur messung von protease-aktivität
NO941781L (no) Ikke-radioaktiv immunanalyse
BRPI0514318A (pt) ensaio de liberação de fluorescência com relação à atividade de protease da toxina do botulismo em gfp-snap25
GB1520261A (en) Tripeptides containing proline and the use thereof in the quantitative determination of enzymes
Lainé et al. Simultaneous kinetic determinations of lipase, chymotrypsin, trypsin, elastase, and amylase on the same microtiter plate
Shinde et al. Folding Pathway Mediated by an Intramolecular Chaperone: Characterization of the Structural Changes in Pro-subtilisin E Coincident with Autoprocess ing
DK1111385T3 (da) Enzym-protein-kompleks
WO2003016904A3 (en) Peptide sequence tags and method of using same
Marokhazi et al. Cleavage site analysis of a serralysin‐like protease, PrtA, from an insect pathogen Photorhabdus luminescens and development of a highly sensitive and specific substrate
AU5381086A (en) Fluorescence polarization assay for amylase
ATE165168T1 (de) Festphasenimmunoassay zum nachweis von inhibitoren von einem proteolytischen enzym
Wildeboer et al. Characterization of bacterial proteases with a panel of fluorescent peptide substrates
Berry et al. Bacterial collagenase and collagen identification
Müller et al. Assay of diverse protease activities on the basis of a small synthetic substrate
BR0108767A (pt) Adenilciclase recombinante, polinucleotìdeo, vetor, processos para a detecção de atividade proteolìtica de uma molécula e da resistência a um inibidor, de uma molécula com atividade proteolìtica e de identificação de moléculas com atividade proteolìtica sìtio-especìfica, kit de diagnóstico, utilização de uma adenilciclase, e, cepa bacteriana
Bordusa et al. Subsite specificity studies on the unusual cysteine protease clostripain: charged residues in the P3 position indicate a narrow subsite region
Maurer et al. Analysis of detergent enzymes
Chen et al. 2-Nitro-5-thiosulfobenzoic acid as a novel inhibitor specific for deoxyribonuclease I
Røyseth et al. Substrate profiling of marine-derived thermotolerant cysteine protease reveals unique cleavage preferences for industrial applications
Richards et al. Inhibition of aspartic proteinases by synthetic peptides derived from the propart region of human prorenin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties